Tesamorelin vs Sermorelin: Cost, Dosing and Fat Loss

Tesamorelin vs Sermorelin: Which One Wins for You?

Tesamorelin wins for targeted visceral fat. It holds FDA approval. Phase 3 trials show 15–20% VAT reduction over 26 weeks. Sermorelin wins for long-term anti-ageing and recovery work. It is gentler and cheaper. It is also easier to keep up for men who want pulsatile GH support without the extra potency.

Both compounds are GHRH analogues. GHRH stands for growth hormone releasing hormone. It is the brain signal that tells the pituitary to act. Both push the pituitary to release your own growth hormone (GH). They differ in structure, potency, evidence, and price. This page sets out each difference. The aim is a choice that matches your goal, not a sales page.

For sourcing these compounds, see the recommended sources page for vetted research suppliers. Background on the stronger of the two sits in the tesamorelin complete guide.

What's the Difference Between Tesamorelin and Sermorelin?

Sermorelin is the 29-amino acid front end of human GHRH. That short chain is the active core of the full 44-amino acid hormone. It binds the GHRH receptor and fires a GH pulse. Then it clears fast. Ishida 2020 puts the half-life at 11–12 minutes. Peak blood levels land 5–20 minutes after a shot. Clearance runs 2.4–2.8 L/min. Each shot gives one discrete pulse lasting roughly 2–4 hours.

Tesamorelin is the whole 44-amino acid sequence. It also carries a trans-3-hexenoic acid group on one end. That group does two jobs. It shields the molecule from enzymes that break it down. It also makes it grip the receptor harder. The result is a stronger, longer GH and IGF-1 response. IGF-1 is the hormone that does most of GH's work in tissue. González-Sales 2015 mapped that profile. IGF-1 rose with dose, and stayed inside the normal range.

Both molecules leave your own feedback loop intact. Your body can still tell the pituitary to ease off. That happens if IGF-1 climbs too high. Walker 2006 calls that the key edge over injected GH. You get the rise without switching off your own control system.

Is Tesamorelin Better Than Sermorelin on Potency?

On raw potency, yes. Tesamorelin drives a higher peak and a bigger IGF-1 rise at standard doses.

The half-life figures look almost identical. Both sit near 11–12 minutes. The gap is in receptor efficacy. Its window runs 26–38 minutes. Sermorelin's runs 10–20. That stronger signal feeds a larger IGF-1 response. In the Phase 3 trials, IGF-1 rose with dose at 2 mg daily. Clemmons 2017 found no real glucose disruption alongside that rise in type 2 diabetics. So the IGF-1 lift appears to stay in a safe band.

Sermorelin moves IGF-1 less. Sermorelin.com 2026 sets out the usual pattern. Changes show up within 4–12 weeks of steady nightly dosing. Over a 3–6 month protocol, the typical rise is 15–25%. The target range is 200–300 ng/mL, whatever the age-adjusted band says.

That gap matters for a man six months into sermorelin who wants more. Tesamorelin will move IGF-1 further and faster. Whether he needs that extra push depends on the goal.

Tesamorelin vs Sermorelin for Visceral Fat: What Does the Evidence Show?

Tesamorelin has the strongest visceral fat data of any GHRH analogue. Sermorelin has nothing comparable.

The gap is not subtle. Tesamorelin won FDA approval for excess visceral fat in HIV-positive adults with lipodystrophy. Two Phase 3 trials carried that approval, and Spooner 2012 summarised both of them. VAT and waist size fell over 26 weeks. The effect held in the extension phases. A 2026 meta-analysis pooled five RCTs. The mean gap against placebo was -27.71 cm². The 95% band ran -38.37 to -17.06, at P<0.001, per Aghimien 2026. A post-hoc look at the Phase 3 data confirmed the effect on modern drug regimens too. That includes integrase strand transfer inhibitors, per McLaughlin 2023.

Sermorelin's fat effects are real but indirect. More GH supports lipolysis, the breakdown of stored fat. Men on 3–6 months of nightly dosing often report a softer waistline firming up. That is not 27 cm² of measured VAT loss in a controlled trial. If visceral fat is the target, tesamorelin sits in a different evidence class.

Sermorelin vs Tesamorelin for Muscle Growth: What Changes?

Neither compound is a mass builder. Both shift body shape slowly, and the measured evidence again favours tesamorelin.

A responder is someone who loses 8% or more of their VAT. Those men also showed more muscle area and higher muscle density at the L4-L5 level. Falutz 2018 calls that real remodelling. Less fat, more working muscle, same protocol.

Sermorelin pulls the same levers with a weaker signal. GH supports protein synthesis and recovery between sessions. Over 3–6 months, men tend to report better muscle quality rather than visible size. Neither peptide replaces training or protein intake.

How Do You Dose Sermorelin or Tesamorelin?

Tesamorelin is 2 mg once daily under the skin, usually in the morning. Sermorelin is 0.2–0.6 mg nightly at bedtime. Both need mixing first. Neither works as a tablet.

The bedtime timing is deliberate. Your pituitary puts out most of its daily GH early. It happens in the first 90 minutes of deep sleep. Dosing 30–60 minutes before bed stacks the signal on top of that natural pulse. Starting doses of 0.2–0.3 mg nightly are common. Some protocols run 0.5–0.6 mg for a stronger effect.

Tesamorelin skips that night-time logic. The FDA-approved Egrifta protocol uses 2 mg in the morning, mixed from two 1 mg vials. CADTH 2016 documents that regimen, and notes the maintenance phase may allow a lower dose. Always work with a qualified clinician before making changes to your health protocol.

In practice, sermorelin asks more of you. Miss bedtime doses and you lose the timing advantage. Tesamorelin's morning shot slots into a routine more easily. For the full dose breakdown, see the tesamorelin dosage protocol. The CJC-1295 complete guide walks through mixing, using the same vial and bacteriostatic water method.

How Much Does Tesamorelin Cost per Month Against Sermorelin?

Brand-name Egrifta runs $2,400–$2,800 per month. That makes it one of the most expensive peptide protocols going. Compounded tesamorelin drops to $800–$1,200 a month. Sermorelin from a compounding pharmacy runs $150–$300.

Several things drive that gap. Tesamorelin has an approved brand product, with the research and manufacturing overhead that carries. Its longer chain is also harder to synthesise. Most tesamorelin plans run 26 weeks or more to get the full VAT effect. Six months of the compounded version costs $4,800–$7,200.

Sermorelin changes the maths for men treating GH support as an ongoing habit. A full year of sermorelin costs roughly what one month of compounded tesamorelin does. Say the goal is slow anti-ageing support, better sleep, and steady recovery. Then sermorelin is the efficient pick.

The useful question is not which is cheaper. It is which price matches the job. Paying for tesamorelin's potency when you want sermorelin's steady support is a mismatch. It is a clinical dose where a maintenance dose would do.

What Are the Side Effects of Tesamorelin and Sermorelin?

Tesamorelin's most common event is a reaction at the injection site. That runs 8–13%, against 5–7% on placebo. Swollen ankles and joint pain follow. So does a modest 3–5 mg/dL rise in fasting glucose. Sermorelin's profile is milder. Expect brief flushing, sore injection sites, and rare whole-body effects.

The glucose signal is worth understanding. Clemmons 2017 found no real change in insulin response or glucose control. That was a 12-week RCT at 1–2 mg daily in type 2 diabetics. The 3–5 mg/dL rise is a known effect of more GH. GH blunts insulin signalling. It is not a sign of harm. Even so, men with existing insulin resistance should monitor fasting glucose regularly. They should also tell their clinician they are running this protocol.

Carpal tunnel symptoms and nerve pain show up at low rates. These are class effects across the GH axis, not tesamorelin quirks. Most resolve when the dose drops or the protocol stops. Spooner 2012 reviewed the Phase 3 extension data. It showed no new safety signals out to 52 weeks.

Sermorelin's intact feedback loop is its main safety edge. The axis can still turn itself down. So the risk of runaway IGF-1 is lower than with injected GH. That makes sermorelin the sensible entry point for a man new to this class. Baseline and follow-up IGF-1 testing is standard clinical practice with either compound.

Can You Take Tesamorelin and Sermorelin Together?

There is no controlled trial of the pair. Both bind the same GHRH receptor. Running both adds dose, not a new mechanism. Most men pick one and reassess later.

Choose tesamorelin if:

• You carry a lot of visceral fat and want trial evidence behind the choice.
• You have a clinician who can monitor fasting glucose and IGF-1 quarterly.
• Your budget covers six months of the compounded version, at $4,800–$7,200.
• You have already worked through what sermorelin can do.
• Lipodystrophy or metabolic syndrome is driving the fat gain.

Choose sermorelin if:

• Your goals are sleep, recovery, skin and connective tissue, and slow lean gains.
• You are new to this class and want a milder, more physiologic start.
• Budget matters and you want a protocol you can sustain.
• You want to pair it with a GHRP such as ipamorelin for a bigger pulse. The ipamorelin vs MK-677 comparison has the stacking logic.
• You want to keep sensitivity in reserve for a later step up.

These are not lifetime choices. Plenty of men in the 35-55 bracket run sermorelin for 6–12 months first. They set an IGF-1 baseline and review the result. Only then do they judge whether tesamorelin's extra potency earns its price.

Where Do CJC-1295 and Ipamorelin Fit Next to Tesamorelin and Sermorelin?

CJC-1295 with DAC sits above both on duration. DAC stands for Drug Affinity Complex, the tag that keeps the molecule circulating. One shot lifts GH for 6–8 days rather than for one daily pulse.

That length cuts both ways. A steady lift may blunt the pulse rhythm the GH axis is built around. Sermorelin's short half-life is a feature by that reading. It fires a pulse, clears, and lets normal feedback reset before the next dose. Tesamorelin sits between the two. It keeps the daily pulse pattern with more amplitude behind it.

The CJC-1295 complete guide has the full mechanism, dosing and stacking picture. For the closest one-to-one matchup, see tesamorelin vs ipamorelin.

Tesamorelin holds a rare spot in this family. It has real regulatory history and trial data. CJC-1295 and most other GHRH analogues have neither. That record sets honest expectations about what it will and will not do.

References

• Rahman F et al. 2023. Effect of tesamorelin in people with HIV with and without dorsocervical fat: post hoc analysis of a phase III trial. PMC9947601.
• González-Sales M et al. 2015. Population pharmacokinetic analysis of tesamorelin. PMID 25358450.
• Spooner LM, Olin JL. 2012. Tesamorelin: a growth hormone-releasing factor analogue for HIV-associated lipodystrophy. PMID 22298602.
• Aghimien I et al. 2026. Meta-analysis of tesamorelin RCTs. ScienceDirect.
• Fourman LT et al. 2021. Tesamorelin response pathways in HIV-associated NAFLD. PMC8131688.
• Walker RF. 2006. Sermorelin for adult-onset growth hormone insufficiency. PMC2699646.
• Sinha DK et al. 2020. Growth hormone secretagogues in body composition management. PMC7108996.
• Clemmons DR et al. 2017. Tesamorelin in type 2 diabetes. PMC5472315.
• McLaughlin T et al. 2023. Tesamorelin reduces VAT and liver fat in INSTI-treated HIV. PMC10678288.
• CADTH 2016. Pharmacoeconomic Review: Tesamorelin (Egrifta). NBK538949.
• Ishida Y, Saitoh M. 2020. Growth hormone secretagogues: history, mechanism of action, and clinical development.
• González-Sales M et al. 2015. PK/PD modelling of tesamorelin growth hormone and IGF-1 response. PMID 25895899.
• Falutz J et al. 2018. Tesamorelin reduces muscle fat and increases muscle area in HIV adults.

This content is for educational purposes only. These compounds are intended for research use. Nothing here is medical advice. Always work with a qualified clinician before making changes to your health protocol.